
Growth hormone output peaks in your late teens and falls roughly 14% per decade after age 30. By 50, your body produces about half the GH it made at 20. IGF-1 — the downstream marker — drops in parallel. This is the physiological driver of the over-40 muscle story: sarcopenia, visceral fat accumulation, slower recovery, and the sense that the same training produces worse results than it did a decade ago.
The direct fix is to restore pulsatile GH release, which is exactly what GHRH+GHRP peptide stacks do. A GHRH analog (sermorelin, CJC-1295, tesamorelin) primes the pituitary; a GHRP (ipamorelin, GHRP-2) triggers release. The combined pulse is 2-3x larger than either alone (Bowers et al., 1990).
This article ranks the peptides that actually work for over-40 users — conservative enough to run long-term, strong enough to meaningfully change the trajectory. No SARMs, no steroids, no gimmicks.
The Somatopause Problem
"Somatopause" is the endocrinology term for age-related GH/IGF-1 decline. It is not a disease, it is a normal biological process, and it is the biggest reason muscle is harder to build and hold after 40. The downstream effects:
- Reduced lean mass: 1-2% loss per year past 50 without intervention
- Increased visceral fat: disproportionate abdominal fat accumulation
- Slower recovery: DOMS lingers longer; training frequency has to drop
- Reduced sleep quality: GH is released in early slow-wave sleep, and the feedback loop degrades with age
- Decreased bone density: IGF-1 supports osteoblast activity
GH peptide stacks directly target the pituitary-to-liver axis that controls all of this. They do not replace the natural rhythm — they amplify it, producing larger pulses while preserving the pulsatile pattern that continuous HGH injection disrupts.
Quick Comparison Table
The Ranking
1. CJC-1295 + Ipamorelin (Blend)
The over-40 default. CJC-1295 without the DAC modification is a modified GRF(1-29) with a ~30-minute effective half-life — long enough to produce a meaningful GH pulse when paired with a GHRP, short enough to preserve physiological pulsatility (Teichman et al., 2006). Paired with ipamorelin (the cleanest GHRP, with no cortisol or prolactin spike — Raun et al., 1998), you get a synergistic pulse 2-3x larger than either alone.
Why this beats both sermorelin (below) and tesamorelin (below) as the default: sermorelin is gentler but weaker; tesamorelin is stronger but more expensive. CJC+ipa hits the sweet spot — strong enough to produce visible body-composition change in 12-16 weeks, accessible at any vendor, priced for multi-cycle use.
Over-40 protocol: 100 mcg CJC-1295 + 100 mcg ipamorelin, subcutaneous, pre-bed fasted (at least 2 hours after last meal). Run 12-16 weeks, off 4-8. Bloodwork at baseline, 4 weeks, 12 weeks.
Deep dive: Best CJC-1295 + Ipamorelin Vendors | CJC-1295 / Ipamorelin Dosing Guide
Top CJC-1295 + Ipamorelin Vendors
Ranked by price, COA availability, and reputation
2. Sermorelin + Ipamorelin
The conservative starting point. Sermorelin is the original synthetic GHRH(1-29) — the gentlest GHRH on this list and the one with the longest clinical track record (FDA-approved for pediatric GH deficiency). Its ~10-minute half-life means the GH pulse per dose is smaller than CJC-1295's, which is a feature when you are new to GH peptides and want to titrate carefully.
Paired with ipamorelin, the stack still produces a synergistic pulse — just a smaller one than CJC+ipa. For over-50 users, or anyone with a cautious approach to endocrine interventions, sermorelin+ipa is the right starter. Most users graduate to CJC+ipa after a first successful cycle.
Over-40 protocol: 200-300 mcg sermorelin + 100 mcg ipamorelin, pre-bed fasted. 12-16 weeks on.
Deep dive: Best Sermorelin Vendors | Sermorelin Dosing Guide | CJC-1295 vs Sermorelin
Top Sermorelin Vendors
Ranked by price, COA availability, and reputation

3. Tesamorelin + Ipamorelin
The strongest GHRH+GHRP stack, reserved for users over 40 whose priority is body recomposition (visceral fat loss + lean mass preservation) rather than gentlest-first-entry. Tesamorelin has the deepest clinical dataset of any GHRH: phase III RCT at 26 weeks showed 15-18% visceral fat reduction and preserved muscle cross-sectional area.
For over-40 users with central obesity and reduced lean mass (the most common aging body-composition pattern), this is the highest-leverage stack. Cost is the trade-off: tesa+ipa runs roughly 1.5-2x the per-cycle cost of CJC+ipa.
Over-40 protocol: 2 mg tesamorelin + 100-200 mcg ipamorelin, pre-bed fasted, 5 days per week. 12-16 weeks.
Deep dive: Best Tesamorelin + Ipamorelin Vendors | Tesamorelin Results Timeline
Top Tesamorelin + Ipamorelin Vendors
Ranked by price, COA availability, and reputation
4. MK-677 (Oral)
The only oral GH secretagogue with strong evidence in older adults specifically. The Nass 2008 RCT in Annals of Internal Medicine studied adults aged 60-81 and showed 1.6 kg fat-free mass gain over 12 months versus placebo — the most direct evidence of any peptide on this list for the over-60 population.
Trade-offs at older ages: fluid retention in weeks 1-6 is more pronounced; the modest rise in fasting glucose requires HbA1c monitoring, especially in anyone with prediabetes or family history of diabetes. Mild drowsiness from pre-bed dosing is usually a feature (better sleep) rather than a bug.
Over-40 protocol: 10-15 mg oral for two weeks (acclimation), then 15-25 mg daily pre-bed. 12 weeks on, 4 off. HbA1c at weeks 8 and 12 mandatory.
Deep dive: MK-677 Dosing Guide | MK-677 Peptide Page
5. Ipamorelin (Solo)
Running ipamorelin alone leaves the GHRH side of the synergy unused — but solo ipamorelin is still a viable GHRP if you already have a GHRH analog from a telehealth provider (sermorelin is common in physician-prescribed protocols) and need a compatible GHRP to complete the stack.
Over-40 protocol: 100-200 mcg ipamorelin pre-bed, paired with an existing GHRH.
Deep dive: Best Ipamorelin Vendors | Ipamorelin Dosing Guide
Top Ipamorelin Vendors
Ranked by price, COA availability, and reputation
6. IGF-1 LR3
The advanced option. IGF-1 LR3 acts directly on muscle IGF-1 receptors, bypassing the GH axis entirely. For over-40 users, this is only worth considering after a full GHRH+GHRP cycle has produced its expected effect and you are looking for additional anabolism.
Hypoglycemia risk matters more at older ages because meal timing is often less consistent. Fast-acting carbs must be available. Never combine with exogenous insulin without medical supervision.
Protocol: 20-50 mcg post-workout, 4-6 days per week. 4-6 weeks max per cycle.
Deep dive: Best IGF-1 LR3 Vendors | IGF-1 LR3 Dosing Guide
Top IGF-1 LR3 Vendors
Ranked by price, COA availability, and reputation

The Over-40 Protocol Fundamentals
Resistance training 3x/week minimum. Compound lifts — squat variation, deadlift or hinge variation, horizontal and vertical press, row — at 70-80% 1RM for 3-5 sets. Lower-volume than younger users can tolerate; more recovery between sessions.
Protein at 1.8-2.2 g/kg target body weight. Age-related anabolic resistance means older muscle responds less to a given protein dose. Spread across 3-4 meals of 30-40 g each.
Sleep is non-negotiable. GH release correlates with early slow-wave sleep depth. Over-40 users with poor sleep hygiene will not get the full GH peptide benefit regardless of dose. 7-8 hours, cool dark room, consistent bedtime.
Cardio is supportive, not central. Zone 2 walking or cycling 3-4x/week for cardiovascular health, not for fat loss. Steroid-era bodybuilding cardio volumes will interfere with recovery from heavy lifting at older ages.
Bloodwork for Over-40 Users
Baseline:
- IGF-1 (primary efficacy marker)
- Fasting glucose, HbA1c (glucose drift risk)
- Fasting insulin
- Comprehensive metabolic panel
- Lipid panel
- Total and free testosterone (men — low T is common over 40 and affects the decision)
- TSH, free T4 (thyroid decline mimics GH decline)
- PSA (men over 45)
- hs-CRP (age-related inflammation)
4 weeks: IGF-1 (target: 30-60% above baseline), fasting glucose.
12 weeks: Full panel. If HbA1c up 0.3%+, dose-reduce.
Quarterly during ongoing cycling. Annual full panel during off-cycles.
How to Choose
First GH peptide, cautious approach → sermorelin + ipamorelin. Lowest dose, gentlest profile, easy to discontinue.
Typical over-40 lifter, moderate budget → CJC-1295 + ipamorelin. Canonical stack, best cost-per-effect.
Central obesity, body recomp priority, budget ok → tesamorelin + ipamorelin.
Can't or won't inject → MK-677 oral, with HbA1c monitoring.
Already running GHRH+GHRP, want more → add IGF-1 LR3 for 4-6 weeks.
For women specifically, the same stacks work at 70-80% of male doses; the decision tree is the same.
Frequently Asked Questions
How much does GH actually decline with age?
Peak GH output is in late adolescence. By age 30, daily GH secretion drops roughly 14% per decade. By age 50, total 24-hour GH output is about half what it was at 20. IGF-1 follows, falling from ~250 ng/mL in young adults to 100-150 ng/mL by the 50s.
Is sermorelin or CJC-1295 better for over-40 users?
Sermorelin is the gentler starting point (10-minute half-life, longest safety record). CJC-1295 (no DAC) has a ~30-minute effective half-life — stronger pulse, same mechanism. Sermorelin+ipa for cautious first-timers; CJC+ipa for standard use.
Can women over 40 run these stacks?
Yes. The GH decline that happens with age affects both sexes. Women typically use the same compounds at 70-80% of the male dose. Tesamorelin's phase III trials included both sexes.
What about MK-677 for older users?
MK-677 has the strongest direct evidence for older adults — Nass 2008 Annals trial in adults 60-81 showed 1.6 kg fat-free mass gain over 12 months. Trade-offs: fluid retention, fasting glucose rise requiring HbA1c monitoring.
How fast should I expect results after 40?
Slightly slower than younger users, but same trajectory. Weeks 1-2: sleep and recovery. Weeks 4-8: body composition shift. Weeks 12+: measurable lean mass. Realistic target: 2-4 lb over 12-16 weeks with proper training.
Do I still need resistance training at this age?
Yes, more than ever. The peptide provides the anabolic signal; lifting provides the mechanical stress that directs tissue preservation. Over-40 users who skip resistance training see the recovery improvement but lose the muscle-building effect.
Is bloodwork more important over 40?
Yes. Baseline IGF-1, fasting glucose, HbA1c, fasting insulin, lipid panel, PSA, and TSH are non-negotiable before starting. Quarterly testing during active cycles; annual full panel during off-cycles.
References
| # |
Citation |
PMID |
| 1 |
Bowers CY, et al. GH-releasing peptide acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 1990;70(4):975-982. |
2108187 |
| 2 |
Falutz J, et al. Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation. J Clin Endocrinol Metab. 2010;95(9):4291-4304. |
20101189 |
| 3 |
Adrian S, et al. Tesamorelin decreases muscle fat and increases muscle area in adults with HIV. J Frailty Aging. 2019;8(3):154-159. |
31237318 |
| 4 |
Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805. |
16352683 |
| 5 |
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. |
9849822 |
| 6 |
Nass R, et al. Effects of an oral ghrelin mimetic on body composition in healthy older adults. Ann Intern Med. 2008;149(9):601-611. |
18981485 |
| 7 |
Pandya N, et al. GHRP-6 requires endogenous hypothalamic GHRH for maximal GH stimulation. J Clin Endocrinol Metab. 1998;83(4):1186-1189. |
9543138 |
| 8 |
Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients. JAMA. 2014;312(4):380-389. |
25038357 |